EyePoint Pharmaceuticals, Inc. (EYPT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 249.5M | 328.65M | 216.11M | 265.25M | 326.98M | 383.31M | 268.55M | 294.93M | 317.71M | 344.8M | 150.16M | 167.12M |
| Cash & Short-Term Investments | 222.54M | 306.09M | 204.02M | 255.73M | 318.19M | 370.91M | 253.79M | 280.25M | 299.35M | 331.05M | 136.01M | 142.53M |
| Cash Only | 77.71M | 101.82M | 74.58M | 71.14M | 85.16M | 99.7M | 79.83M | 90.77M | 271.01M | 281.26M | 133.03M | 139.6M |
| Short-Term Investments | 144.83M | 204.26M | 129.44M | 184.59M | 233.04M | 271.21M | 173.96M | 189.48M | 28.34M | 49.79M | 2.98M | 2.94M |
| Accounts Receivable | 1.16M | 651K | 1.04M | 625K | 442K | 607K | 378K | 1.38M | 3.02M | 805K | 483K | 10.95M |
| Days Sales Outstanding | 116.9 | 125.83 | 79.52 | 9.1 | 1.93 | 3.91 | 7.66 | 21.08 | 14.88 | 4.22 | 34.6 | 106.81 |
| Inventory | 1.25M | 1.81M | 2.11M | 2.68M | 2.13M | 2.31M | 2.81M | 3.67M | 4.26M | 3.91M | 4.58M | 4.26M |
| Days Inventory Outstanding | 261.05 | 481.22 | 305.48 | 1.33K | 247.86 | 288.18 | 404.94 | 257.51 | 489.35 | 391 | 338.23 | 211.55 |
| Other Current Assets | 24.55M | 20.11M | 8.93M | 6.21M | 1.4M | 1.41M | 1.3M | 1.06M | 1.48M | 1.01M | 9.09M | 9.37M |
| Total Non-Current Assets | 38.71M | 35.34M | 35.59M | 35.9M | 35.58M | 35.16M | 32.37M | 29.32M | 11.54M | 10.38M | 9.88M | 8.54M |
| Property, Plant & Equipment | 19.78M | 20.22M | 29.52M | 21.09M | 29.55M | 29.18M | 29.8M | 29.17M | 11.39M | 10.23M | 9.73M | 8.39M |
| Fixed Asset Turnover | 0.03x | 0.02x | 0.04x | 0.21x | 0.83x | 0.39x | 0.36x | 0.47x | 1.08x | 1.41x | 1.68x | 1.09x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 150K | 150K | 0 | 0 |
| Other Non-Current Assets | 18.94M | 15.12M | 6.07M | 14.81M | 6.03M | 5.98M | 2.57M | 150K | 0 | 0 | 150K | 150K |
| Total Assets | 288.22M | 364M | 251.69M | 301.15M | 362.56M | 418.46M | 300.92M | 324.25M | 329.25M | 355.18M | 160.04M | 175.66M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.02x | 0.06x | 0.03x | 0.03x | 0.03x | 0.03x | 0.05x | 0.09x | 0.06x |
| Asset Growth % | -20.51% | -13.02% | -16.36% | -7.12% | 10.12% | 17.82% | 88.02% | 84.59% | 112.98% | 96.94% | -27.41% | -24.75% |
| Total Current Liabilities | 37.46M | 37.02M | 30.09M | 33.17M | 41.68M | 49.05M | 48.79M | 62.1M | 62.58M | 63.26M | 63.9M | 68.92M |
| Accounts Payable | 35.25M | 34.88M | 28.02M | 31.16M | 16.42M | 11.72M | 7.34M | 14.3M | 7.08M | 6.5M | 9.58M | 10.72M |
| Days Payables Outstanding | 5.98K | 7.72K | 3.78K | 13.12K | 1.57K | 1.07K | 1.35K | 694.29 | 814.44 | 741.35 | 776.76 | 512.13 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1M | 563K | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 5.12M | 17.78M | 26M | 33.34M | 38.38M | 38.59M | 39.84M | 42.08M |
| Other Current Liabilities | 2.21M | 2.14M | 2.08M | 2.01M | 5.59M | 13.27M | 10.2M | 6.99M | 10.52M | 4.97M | 8.47M | 6.27M |
| Current Ratio | 6.66x | 8.88x | 7.18x | 8.00x | 7.85x | 7.81x | 5.50x | 4.75x | 5.08x | 5.45x | 2.35x | 2.42x |
| Quick Ratio | 6.63x | 8.83x | 7.11x | 7.91x | 7.79x | 7.77x | 5.45x | 4.69x | 5.01x | 5.39x | 2.28x | 2.36x |
| Cash Conversion Cycle | -5.6K | -7.11K | -3.39K | -11.79K | -1.32K | -782.6 | -939.84 | -415.7 | -310.22 | -346.12 | -403.93 | -193.76 |
| Total Non-Current Liabilities | 20.28M | 20.86M | 21.42M | 21.96M | 22.49M | 32.92M | 33.39M | 33.84M | 16.73M | 25.6M | 37.53M | 49.48M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 20.23M | 20.77M | 21.3M | 21.82M | 22.31M | 21.86M | 21.92M | 22.16M | 4.62M | 4.91M | 5.18M | 5.46M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -20.69M | 0 | 0 |
| Other Non-Current Liabilities | 55K | 87K | 118K | 148K | 177K | 205K | 233K | 0 | 0 | 20.69M | 0 | 0 |
| Total Liabilities | 57.74M | 57.88M | 51.51M | 55.14M | 64.17M | 81.96M | 82.18M | 95.94M | 79.31M | 88.86M | 101.42M | 118.39M |
| Total Debt | 20.23M | 20.77M | 21.3M | 21.82M | 24.08M | 21.86M | 21.92M | 23.29M | 5.72M | 5.47M | 6.24M | 6.42M |
| Net Debt | -57.48M | -81.05M | -53.28M | -49.33M | -61.08M | -77.85M | -57.91M | -67.47M | -265.29M | -275.79M | -126.79M | -133.17M |
| Debt / Equity | 0.09x | 0.07x | 0.11x | 0.09x | 0.08x | 0.06x | 0.10x | 0.10x | 0.02x | 0.02x | 0.11x | 0.11x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -2949.64x | - | - | - | - | - | -51.69x |
| Total Equity | 230.47M | 306.11M | 200.18M | 246.01M | 298.4M | 336.5M | 218.73M | 228.31M | 249.93M | 266.32M | 58.62M | 57.26M |
| Equity Growth % | -22.76% | -9.03% | -8.48% | 7.75% | 19.39% | 26.35% | 273.13% | 298.7% | 218.83% | 176.36% | -57.01% | -62.17% |
| Book Value per Share | 2.68 | 3.69 | 2.85 | 3.52 | 4.28 | 5.21 | 4.02 | 4.29 | 4.72 | 6.32 | 1.53 | 1.52 |
| Total Shareholders' Equity | 230.47M | 306.11M | 200.18M | 246.01M | 298.4M | 336.5M | 218.73M | 228.31M | 249.93M | 266.32M | 58.62M | 57.26M |
| Common Stock | 1.42B | 1.41B | 70K | 69K | 69K | 68K | 53K | 52K | 50K | 49K | 35K | 34K |
| Retained Earnings | -1.19B | -1.1B | -1.04B | -977.64M | -918.21M | -873.02M | -831.62M | -802.26M | -771.43M | -742.15M | -728.05M | -715.43M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 802K | 961K | 919K | 832K | 923K | 1.03M | 1.17M | 792K | 836K | 864K | 841K | 842K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |